statistiche ricercatore

MANCINI, NICASIO

Distribuzione geografica

Continente	#
EU - Europa	2.970
NA - Nord America	1.967
AS - Asia	730
SA - Sud America	67
OC - Oceania	6
AF - Africa	5
Continente sconosciuto - Info sul continente non disponibili	2
Totale	5.747

Salva come PNG Salva come JPEG

Nazione	#
IT - Italia	2.163
US - Stati Uniti d'America	1.923
SG - Singapore	491
RU - Federazione Russa	163
IE - Irlanda	152
DE - Germania	109
UA - Ucraina	85
CN - Cina	79
FI - Finlandia	70
BR - Brasile	64
TR - Turchia	62
GB - Regno Unito	61
SE - Svezia	57
CA - Canada	39
AT - Austria	31
HK - Hong Kong	29
FR - Francia	25
VN - Vietnam	24
JP - Giappone	20
BE - Belgio	17
NL - Olanda	16
IN - India	15
LT - Lituania	7
CH - Svizzera	6
AU - Australia	5
IQ - Iraq	3
MX - Messico	3
ZA - Sudafrica	3
BD - Bangladesh	2
EC - Ecuador	2
EU - Europa	2
KR - Corea	2
PL - Polonia	2
CL - Cile	1
CR - Costa Rica	1
CZ - Repubblica Ceca	1
DK - Danimarca	1
EE - Estonia	1
EG - Egitto	1
ES - Italia	1
GE - Georgia	1
GT - Guatemala	1
IR - Iran	1
NZ - Nuova Zelanda	1
PH - Filippine	1
RS - Serbia	1
SK - Slovacchia (Repubblica Slovacca)	1
SN - Senegal	1
Totale	5.747

Salva come PNG Salva come JPEG

Città	#
Milan	1.380
Ashburn	217
Boardman	208
Singapore	166
Chicago	163
Dublin	148
Fairfield	141
Rome	114
Chandler	94
Varese	88
The Dalles	77
Jacksonville	72
Seattle	71
Woodbridge	55
Como	54
Ogden	49
Los Angeles	47
Houston	46
Wilmington	45
Ann Arbor	41
Washington	41
Dallas	37
Nyköping	35
Santa Clara	34
Cambridge	32
Toronto	32
Princeton	30
Hong Kong	26
Izmir	26
Magnago	26
Vienna	26
Frankfurt am Main	25
Helsinki	24
Dearborn	23
Brussels	17
San Diego	17
Tokyo	16
London	15
Nuremberg	15
Lappeenranta	13
Assago	12
West Jordan	12
Pune	11
Council Bluffs	10
Munich	10
Düsseldorf	9
Dong Ket	8
Verona	8
Berlin	7
Falkenstein	7
Ottawa	7
Hounslow	6
New York	6
Shanghai	6
Belo Horizonte	5
Brasília	5
Chiswick	5
Genoa	5
Kilburn	5
Amsterdam	4
Beijing	4
Bodio Lomnago	4
Cernusco sul Naviglio	4
Nanjing	4
Paris	4
Portsmouth	4
Sulmona	4
Usmate Velate	4
Acton	3
Baoding	3
Gorgonzola	3
Hefei	3
Jinan	3
Norwalk	3
Phoenix	3
Rio de Janeiro	3
Romola	3
São Paulo	3
Turin	3
Arezzo	2
Barnet	2
Bologna	2
Campinas	2
Cesa	2
Chennai	2
Clyde North	2
Columbia	2
Desio	2
Giussano	2
Goiânia	2
Guiyang	2
Johannesburg	2
Kunming	2
Lugano	2
Maceió	2
Mountain View	2
Naples	2
Niikura	2
Novate Milanese	2
Pescara	2
Totale	4.041

Salva come PNG Salva come JPEG

Nome	#
Antigen-driven evolution of B lymphocytes in coronary atherosclerotic plaques.	147
Monoclonal antibodies isolated from human B cells neutralize a broad range of H1 subtype influenza A viruses including swine-origin Influenza virus (S-OIV).	140
Anti-HIV-1 response elicited in rabbits by anti-idiotype monoclonal antibodies mimicking the CD4-binding site.	138
Coronaviridae and SARS-associated coronavirus strain HSR1.	138
Quantitation of Bacillus clausii in biological samples by real-time polymerase chain reaction.	131
Cross-reactive pseudovirus-neutralizing anti-envelope antibodies coexist with antibodies devoid of such activity in persistent hepatitis C virus infection.	129
Cloning and molecular characterization of a human recombinant IgG Fab binding to the Tat protein of human immunodeficiency virus type 1 (HIV-1) derived from the repertoire of a seronegative patient.	119
Circulating SARS-CoV-2 variants in Italy, October 2020-March 2021	101
Heterogeneity of the humoral anti-HCV/E2 response in persistently infected patients as demonstrated by divergent patterns of inhibition of the binding of anti-HCV/E2 human monoclonal antibodies.	96
A phage display vector optimized for the generation of human antibody combinatorial libraries and the molecular cloning of monoclonal antibody fragments.	92
Phage display for the production of human monoclonal antibodies against human pathogens.	90
Humoral immune response against hepatitis C virus.	85
Molecular cloning of the first human monoclonal antibodies neutralizing with high potency swine-origin influenza A pandemic virus (S-OIV).	84
SARS-CoV-2 detection in primary thyroid sarcoma: coincidence or interaction?	73
A diet enriched in omega-3 PUFA and inulin prevents type 1 diabetes by restoring gut barrier integrity and immune homeostasis in NOD mice	68
A spatial multi-scale fluorescence microscopy toolbox discloses entry checkpoints of SARS-CoV-2 variants in Vero E6 cells	67
In Vitro Antimicrobial Activity of the Siderophore Cephalosporin Cefiderocol against Acinetobacter baumannii Strains Recovered from Clinical Samples	66
Characterization of a Lineage C.36 SARS-CoV-2 Isolate with Reduced Susceptibility to Neutralization Circulating in Lombardy, Italy	64
Levofloxacin prophylaxis vs no prophylaxis in neutropenic patients within an endemic country for carbapenem-resistant GNB	55
Nanopore ReCappable sequencing maps SARS-CoV-2 5' capping sites and provides new insights into the structure of sgRNAs	54
Broadly neutralizing anti-influenza human monoclonal antibodies and their possible role in predictive medicine	53
Adoptive T-cell therapy in the treatment of viral and opportunistic fungal infections	52
A biologically-validated HCV E1E2 heterodimer structural model	51
Analysis of the faecal microbiome during analytical treatment interruption in people with chronic HIV infection and long-lasting virological suppression (APACHE study)	50
Neutralization Interfering Antibodies: a "Novel" Mechanism of Humoral Immune Mutiny and Viral Evasion?	49
A non-VH1-69 heterosubtypic neutralizing human monoclonal antibody protects mice against H1N1 and H5N1 viruses	46
Molecular characterization of the human neutralizing response against hepatitis C virus and its role in the prediction of the infection outcome	46
Anti-hepatitis C virus E2 (HCV/E2) glycoprotein monoclonal antibodies and neutralization interference	46
Identification of a novel mutation involved in colistin resistance in Klebsiella pneumoniae through Next-Generation Sequencing (NGS) based approaches	46
Characterization of epitopes recognized by monoclonal antibodies: experimental approaches supported by freely accessible bioinformatic tools	45
The efficacy of ultraviolet light-emitting technology against coronaviruses: a systematic review	45
Clinical characterization and whole genome sequence-based typing of two cases of endophthalmitis due to Listeria monocytogenes	45
IFCC interim guidelines on rapid point-of-care antigen testing for SARS-CoV-2 detection in asymptomatic and symptomatic individuals	45
Chimeric antigen receptor (CAR)-engineered T cells redirected against hepatitis C virus (HCV) E2 glycoprotein	44
Sites of vulnerability in HCV E1E2 identified by comprehensive functional screening	44
Viral respiratory pathogens and lung Injury	44
Maturation signatures of conventional dendritic cell subtypes in COVID‐19 suggest direct viral sensing	43
SARS-CoV-2 infection despite high levels of vaccine-induced anti-Receptor-Binding-Domain antibodies: a study on 1110 health-care professionals from a northern Italian university hospital	43
Autoimmune hepatitis and occult HCV infection: A prospective single-centre clinical study	43
Heterosubtypic protection conferred by the human monoclonal antibody PN-SIA28 against influenza A virus lethal infections in mice	42
Differential composition of vaginal microbiome, but not of seminal microbiome, is associated with successful intrauterine insemination in couples with idiopathic infertility: A prospective observational study	42
A Human Monoclonal Antibody with Neutralizing Activity against Highly Divergent Influenza Subtypes	42
A case of psoriatic arthritis triggered by SARS-CoV-2 infection	42
Geographical and temporal distribution of SARS-CoV-2 clades in the WHO European Region, January to June 2020	42
Novel therapeutic investigational strategies to treat severe and disseminated HSV infections suggested by a deeper understanding of in vitro virus entry processes	41
High Risk of Secondary Infections Following Thrombotic Complications in Patients With COVID-19	41
Dose-Dependent Impairment of the Immune Response to the Moderna-1273 mRNA Vaccine by Mycophenolate Mofetil in Patients with Rheumatic and Autoimmune Liver Diseases	41
Phage display-based strategies for cloning and optimization of monoclonal antibodies directed against human pathogens	41
JC polyomavirus (JCV) and monoclonal antibodies: friends or potential foes?	40
Proper Selection of In Vitro Cell Model Affects the Characterization of the Neutralizing Antibody Response against SARS-CoV-2	39
Risks of "blind" automated identification systems in medical microbiology	39
Type III interferons disrupt the lung epithelial barrier upon viral recognition	39
Identification of novel molecules supporting the impact of β-lactams against clinically-relevant Gram-negative multidrug resistant organisms	39
Fast inactivation of SARS-CoV-2 by UV-C and ozone exposure on different materials	38
Harmonization of six quantitative SARS-CoV-2 serological assays using sera of vaccinated subjects	38
Molecular diagnosis of sepsis in neutropenic patients with haematological malignancies	38
Acute respiratory distress in a neutropenic febrile patient after hematopoietic cell transplantation	38
Hepatitis C virus (HCV) infection may elicit neutralizing antibodies targeting epitopes conserved in all viral genotypes	38
Unconventional CD147-dependent platelet activation elicited by SARS-CoV-2 in COVID-19	38
Microbiome markers are early predictors of acute GvHD in allogeneic hematopoietic stem cell transplant recipients	38
IFCC interim guidelines on serological testing of antibodies against SARS-CoV-2	38
Very high SARS-CoV-2 load at the emergency department presentation strongly predicts the risk of admission to the intensive care unit and death	38
Operational considerations and challenges of biochemistry laboratories during the COVID-19 outbreak: An IFCC global survey	38
Laboratory practices to mitigate biohazard risks during the COVID-19 outbreak: an IFCC global survey	37
Global and local envelope protein dynamics of hepatitis C virus determine broad antibody sensitivity	37
Direct sequencing of Scedosporium apiospermum DNA in the diagnosis of a case of keratitis	37
Structural and antigenic definition of hepatitis C virus E2 glycoprotein epitopes targeted by monoclonal antibodies	37
Combined prophylactic and therapeutic use maximizes hydroxychloroquine anti-SARS-CoV-2 effects in vitro	36
Naringenin is a powerful inhibitor of SARS-CoV-2 infection in vitro	36
COVID-eVax, an electroporated DNA vaccine candidate encoding the SARS-CoV-2 RBD, elicits protective responses in animal models	36
The interferon landscape along the respiratory tract impacts the severity of COVID-19	36
Possible future monoclonal antibody (mAb)-based therapy against arbovirus infections	36
Microbiome studies in the medical sciences and the need for closer multidisciplinary interplay	35
Early molecular diagnosis of aspergillosis in a patient with acute myeloid leukaemia	35
Molecular, serological, and biochemical diagnosis and monitoring of COVID-19: IFCC taskforce evaluation of the latest evidence	35
Adjuvant role of SeptiFast to improve the diagnosis of sepsis in a large cohort of hematological patients	35
Interferon-β-1a inhibition of severe acute respiratory syndrome–Coronavirus 2 in vitro when administered after virus infection	35
Enteric microbiome markers as early predictors of clinical outcome in allogeneic hematopoietic stem cell transplant (allo-HSCT): results of a prospective study in adult patients	35
Antibody Titer Kinetics and SARS-CoV-2 Infections Six Months after Administration with the BNT162b2 Vaccine	34
Weak correlation between antibody titers and neutralizing activity in sera from SARS-CoV-2 infected subjects	34
Answer to photo quiz: Streptococcus pneumoniae	33
IL-1 and IL-6 inhibition affects the neutralising activity of anti-SARS-CoV-2 antibodies in patients with COVID-19	33
Diverging effects of human recombinant anti-hepatitis C virus (HCV) antibody fragments derived from a single patient on the infectivity of a vesicular stomatitis Virus/HCV pseudotype	33
A human stem cell-derived neurosensory–epithelial circuitry on a chip to model herpes simplex virus reactivation	32
Molecular signatures of hepatitis C virus (HCV)-induced type II mixed cryoglobulinemia (MCII)	32
Natural Flavonoid Derivatives Have Pan-Coronavirus Antiviral Activity	30
A modified Frosch approach for posterior tibial plateau fractures: technical note and case series	29
A novel expression vector for production of epitope-tagged recombinant Fab-fragment in bacteria	28
An outbreak caused by multidrug-resistant OXA-58-positive Acinetobacter baumannii in an intensive care unit in Italy	28
Dual-domain reporter approach for multiplex identification of major SARS-CoV-2 variants of concern in a microarray-based assay	28
Synergy evaluation of anti-Herpes Simplex Virus type 1 and 2 compounds acting on different steps of virus life cycle	26
Lack of efficacy of Interferon β-1a in COVID-19 patients with mild to moderate pneumonia	26
A closer look at prion strains: characterization and important implications	25
A potential role for monoclonal antibodies in prophylactic and therapeutic treatment of influenza	24
Sex-specific Alterations in the Urinary and Tissue Microbiome in Therapy-naïve Urothelial Bladder Cancer Patients	24
A family cluster of Streptococcus pyogenes associated with a fatal early-onset neonatal sepsis	24
The IN SIGNO project: Identification of novel molecules supporting the impact of β-lactams against clinically-relevant Gram-negative multidrug resistant organisms	24
Mechanisms of Hepatitis C Virus Escape from Vaccine-Relevant Neutralizing Antibodies	24
Cell-to-cell spread-blocking activity is extremely limited in the sera of HSV-1 and HSV-2 infected subjects	24
HCV Proteins and Immunoglobulin Variable Gene (IgV) Subfamilies in HCV-Induced Type II Mixed Cryoglobulinemia: A Concurrent Pathogenetic Role	24
Totale	4.924

Salva come PNG Salva come JPEG

Categoria	#
all - tutte	48.672
article - articoli	0
book - libri	0
conference - conferenze	0
curatela - curatele	0
other - altro	0
patent - brevetti	0
selected - selezionate	0
volume - volumi	0
Totale	48.672

Salva come PNG Salva come JPEG

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2019/2020	40	0	0	0	0	0	0	0	0	0	20	2	18
2020/2021	185	3	20	4	22	5	20	18	17	29	6	16	25
2021/2022	219	11	43	20	17	4	0	35	21	16	21	11	20
2022/2023	704	19	7	13	34	34	52	0	39	267	129	35	75
2023/2024	2.699	371	395	336	500	572	254	23	55	79	66	12	36
2024/2025	1.910	24	58	629	141	102	159	134	134	353	176	0	0
Totale													6.228